Effects of high glucose and high insulin concentrations on osteoblast function in vitro (Q38991825)

8 September 2017

title

Effects of high glucose and high insulin concentrations on osteoblast function in vitro (English)

1 reference

8 September 2017

0 references

0 references

Juliana S Cunha

1

1 reference

8 September 2017

Vanessa M Ferreira

2

1 reference

8 September 2017

Edgar Maquigussa

3

1 reference

8 September 2017

Marcelo A Naves

4

1 reference

8 September 2017

Mirian A Boim

5

1 reference

8 September 2017

publication date

25 May 2014

1 reference

8 September 2017

published in

Cell and Tissue Research

1 reference

8 September 2017

volume

358

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

249-256

1 reference

Adynamic bone in patients with chronic kidney disease

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Glucose-induced inhibition of in vitro bone mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

CKD-MBD: an endless story

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Biochemical Markers of Bone Metabolism: An Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Normal bone anatomy and physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Vitamin D Receptor Activation: Clinical Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Renal function and risk of hip and vertebral fractures in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: the health, aging, and body composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Kidney function predicts the rate of bone loss in older individuals: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

High glucose concentrations alter the biomineralization process in human osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

The role of the osteoprotegerin/RANKL/RANK system in diabetic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

21 January 2018

Bone disease in diabetes

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Glucose transport in brain and retina: implications in the management and complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

21 January 2018

Type 2 diabetes and bone

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Role of parathyroid hormone-related protein in the decreased osteoblast function in diabetes-related osteopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Osteoporosis and risk of fracture in patients with diabetes: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

CKD–Mineral and Bone Disorder: Core Curriculum 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Type 2 diabetes and bone fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Effect of Rosiglitazone on Bone Quality in a Rat Model of Insulin Resistance and Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Supply and demand in cerebral energy metabolism: the role of nutrient transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Expression and regulation by insulin of GLUT 3 in UMR 106-01, a clonal rat osteosarcoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

High d( )glucose concentration inhibits RANKL-induced osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

1,25(OH)2D3 inhibits the deleterious effects induced by high glucose on osteoblasts through undercarboxylated osteocalcin and insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Impact of diabetes and its treatments on skeletal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

RANKL Is a Downstream Mediator for Insulin-Induced Osteoblastic Differentiation of Vascular Smooth Muscle Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

Stimulation of glucose transport in osteoblastic cells by parathyroid hormone and insulin-like growth factor I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00441-014-1913-X

10.1007/S00441-014-1913-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1022812053

0 references

Fatcat ID

release_xvz34rnnyzfk5fduqd75zn7zfy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xvz34rnnyzfk5fduqd75zn7zfy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference